Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Axon shares get 'long-term buy' rating with $380 price target from Argus

Published 13/03/2024, 13:42
Updated 13/03/2024, 13:42
© Reuters.

On Wednesday, Argus initiated coverage on Axon Enterprise (NASDAQ:AXON) with a Buy rating and set a price target of $380.00. The firm highlighted Axon's role as a public safety technology company, developing a range of products including TASER stun guns, body cameras, dash-mounted patrol car cameras, and drones. These products have been increasingly sought after by local, state, and federal law enforcement agencies.

The company is also expanding its offerings by bundling these products with software solutions that aid in resource management. Axon's commitment to growth is evident in its expanding research and development efforts. The firm's analysts project that Axon's revenues will continue to grow and that its shares will outperform the broader market. This optimism is attributed to the strong management team and solid earnings prospects, as demand for Axon's products and solutions remains robust.

Argus anticipates that Axon Enterprise will continue to deliver positive earnings surprises, citing the company's tendency for conservative forecasts. With a total addressable market estimated at $60 billion for its products, Axon is expected to capture a significant share of this opportunity. The firm's long-term outlook on Axon is positive, reinforcing the Buy rating.

InvestingPro Insights

As Argus initiates coverage on Axon Enterprise (NASDAQ:AXON) with a bullish stance, it's worth highlighting key financial metrics and insights that align with the company's growth narrative. According to real-time data from InvestingPro, Axon boasts a robust revenue growth rate, with the last twelve months as of Q4 2023 showing a 31.38% increase. This growth is underpinned by a strong gross profit margin of 61.11%, reflecting the company's ability to maintain profitability while expanding its suite of public safety technology products.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The InvestingPro Tips also shed light on Axon's financial health and market sentiment. Notably, Axon holds more cash than debt on its balance sheet, which could provide the flexibility needed for continued R&D investments and product innovation. Moreover, analysts have revised their earnings upwards for the upcoming period, signaling confidence in the company’s earning potential. With 7 analysts making such revisions, this consensus may suggest that Axon's conservative forecasts could indeed lead to positive earnings surprises as anticipated by Argus.

While Axon's P/E ratio stands high at 132.55, reflecting a premium valuation, it's important to consider the company's growth prospects and market position. Investors looking to delve deeper into Axon's financials and future outlook can find additional insights on InvestingPro. There are 21 more InvestingPro Tips available, which could further inform investment decisions. For those interested, using the coupon code PRONEWS24 will provide an additional 10% off a yearly or biyearly Pro and Pro+ subscription, offering a comprehensive view of Axon's investment potential.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.